对加拿大市售癫痫发作检测可穿戴设备的评估：当前证据。

IF 2.9 4区医学 Q2 CLINICAL NEUROLOGY

Canadian Journal of Neurological Sciences Pub Date : 2024-04-04 DOI:10.1017/cjn.2024.58

Yassine Lamrani, Amirhossein Jahani, Laura Gagliano, Dang Khoa Nguyen, Elie Bou Assi

{"title":"对加拿大市售癫痫发作检测可穿戴设备的评估：当前证据。","authors":"Yassine Lamrani, Amirhossein Jahani, Laura Gagliano, Dang Khoa Nguyen, Elie Bou Assi","doi":"10.1017/cjn.2024.58","DOIUrl":null,"url":null,"abstract":"Wearable-based seizure detection devices hold promise in reducing seizure-related adverse events and relieving the daily stress experienced by people with epilepsy. In this work, we present the latest evidence regarding the performance of three seizure detection wearables (eight studies) commercially available in Canada to provide guidance to clinicians. Overall, their ability to detect focal-to-bilateral and/or generalized tonic-clonic seizures ranges between 21.0% and 98.15% in sensitivity, with the 24h false alarm rates ranging from 0 to 1.28. While performance in epilepsy monitoring units show promise, the lack of evidence in outpatient settings precludes strong recommendations for their use in daily life.","PeriodicalId":56134,"journal":{"name":"Canadian Journal of Neurological Sciences","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of Commercially Available Seizure Detection Wearables in Canada: Current Evidence.\",\"authors\":\"Yassine Lamrani, Amirhossein Jahani, Laura Gagliano, Dang Khoa Nguyen, Elie Bou Assi\",\"doi\":\"10.1017/cjn.2024.58\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Wearable-based seizure detection devices hold promise in reducing seizure-related adverse events and relieving the daily stress experienced by people with epilepsy. In this work, we present the latest evidence regarding the performance of three seizure detection wearables (eight studies) commercially available in Canada to provide guidance to clinicians. Overall, their ability to detect focal-to-bilateral and/or generalized tonic-clonic seizures ranges between 21.0% and 98.15% in sensitivity, with the 24h false alarm rates ranging from 0 to 1.28. While performance in epilepsy monitoring units show promise, the lack of evidence in outpatient settings precludes strong recommendations for their use in daily life.\",\"PeriodicalId\":56134,\"journal\":{\"name\":\"Canadian Journal of Neurological Sciences\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Neurological Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1017/cjn.2024.58\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/cjn.2024.58","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

基于可穿戴设备的癫痫发作检测设备有望减少与癫痫发作相关的不良事件，减轻癫痫患者的日常压力。在这项工作中，我们介绍了有关加拿大市售的三种癫痫发作检测可穿戴设备（八项研究）性能的最新证据，以便为临床医生提供指导。总体而言，它们检测局灶至双侧和/或全身强直阵挛发作的灵敏度在 21.0% 到 98.15% 之间，24 小时误报率在 0 到 1.28 之间。虽然在癫痫监测单位中的表现很有希望，但在门诊环境中缺乏证据，因此不能强烈建议在日常生活中使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Evaluation of Commercially Available Seizure Detection Wearables in Canada: Current Evidence.

Wearable-based seizure detection devices hold promise in reducing seizure-related adverse events and relieving the daily stress experienced by people with epilepsy. In this work, we present the latest evidence regarding the performance of three seizure detection wearables (eight studies) commercially available in Canada to provide guidance to clinicians. Overall, their ability to detect focal-to-bilateral and/or generalized tonic-clonic seizures ranges between 21.0% and 98.15% in sensitivity, with the 24h false alarm rates ranging from 0 to 1.28. While performance in epilepsy monitoring units show promise, the lack of evidence in outpatient settings precludes strong recommendations for their use in daily life.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Canadian Journal of Neurological Sciences 医学-临床神经学

CiteScore

4.30

自引率

3.30%

发文量

330

审稿时长

4-8 weeks

期刊介绍： Canadian Neurological Sciences Federation The Canadian Journal of Neurological Sciences is the official publication of the four member societies of the Canadian Neurological Sciences Federation -- Canadian Neurological Society (CNS), Canadian Association of Child Neurology (CACN), Canadian Neurosurgical Society (CNSS), Canadian Society of Clinical Neurophysiologists (CSCN). The Journal is a widely circulated internationally recognized medical journal that publishes peer-reviewed articles. The Journal is published in January, March, May, July, September, and November in an online only format. The first Canadian Journal of Neurological Sciences (the Journal) was published in 1974 in Winnipeg. In 1981, the Journal became the official publication of the member societies of the CNSF.